WASHINGTON UNIVERSITY
Harnessing mitochondria transfer pathways to ameliorate Leigh Syndrome-like disease
Harnessing mitochondria transfer pathways to ameliorate Leigh Syndrome-like disease is a funding opportunity from WASHINGTON UNIVERSITY, up to 584115, closing June 30, 2029.
Jun 30, 2029
(1065d left)Overview
PROJECT SUMMARY Leigh Syndrome (LS) is an inherited mitochondrial disease that presents with prominent neurologic symptoms and death in childhood. There are currently no effective therapies for this devastating disease, highlighting an urgent need to identify novel biological pathways that can be targeted…